About Hy2Care
Hy2Care is a company based in Enschede (Netherlands) founded in 2014 by Chris Cardinaels.. Hy2Care has raised $15.49 million across 6 funding rounds from investors including European Union, ReumaNederland and Brightlands Venture Partners. Hy2Care offers products and services including CartRevive Hydrogel Implant. Hy2Care operates in a competitive market with competitors including NexGel Biotech, Bone Sci and Sumatrix Biotech, among others.
- Headquarter Enschede, Netherlands
- Founders Chris Cardinaels
-
Sectors
HealthcareChemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.49 M (USD)
in 6 rounds
-
Latest Funding Round
$5.04 M (USD), Series B
May 16, 2025
-
Investors
European Union
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hy2Care
Hy2Care offers a comprehensive portfolio of products and services, including CartRevive Hydrogel Implant. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hydrogel for facilitating natural cartilage defect repair and healing.
Unlock access to complete
Leadership Team
2 people
Finance and Accounting
1 people
Operations Team
1 people
COO Team
1 people
Unlock access to complete
Funding Insights of Hy2Care
Hy2Care has successfully raised a total of $15.49M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $5.04 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $5.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - Hy2Care | Valuation | Brightlands Venture Partners | |
| Jun, 2022 | Amount | Series B - Hy2Care | Valuation |
investors |
|
| May, 2019 | Amount | Series A - Hy2Care | Valuation | Brightlands Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hy2Care
Hy2Care has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, ReumaNederland and Brightlands Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brightlands Venture Partners is focused on venture capital investments.
|
Founded Year | Domain | Location | |
|
LIOF is engaged in supporting innovative entrepreneurs in Limburg.
|
Founded Year | Domain | Location | |
|
Tech focused global accelerator firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hy2Care
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hy2Care
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hy2care Comparisons
Competitors of Hy2Care
Hy2Care operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NexGel Biotech, Bone Sci and Sumatrix Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hydrogels for wound healing and bone regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Bone Sci specializes in orthobiologics solutions for effective bone regeneration.
|
|
| domain | founded_year | HQ Location |
Produces high-quality hydrogel materials for various applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Hy2Care
When was Hy2Care founded?
Hy2Care was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Hy2Care located?
Hy2Care is headquartered in Enschede, Netherlands. It is registered at Enschede, Overijssel, Netherlands.
Who is the current CEO of Hy2Care?
Leo Smit is the current CEO of Hy2Care.
Is Hy2Care a funded company?
Hy2Care is a funded company, having raised a total of $15.49M across 6 funding rounds to date. The company's 1st funding round was a Series A of $4.15M, raised on Jul 14, 2015.
What does Hy2Care do?
Hy2Care was founded in 2014 in Enschede, Netherlands, within the medical technology sector focused on regenerative orthopedics. A hydrogel-based implant is developed to address cartilage defects in joints, serving as a biocompatible scaffold that supports cellular regeneration. Operations center on creating materials that integrate with natural tissue, enabling repair processes to reduce pain and maintain joint mobility while mitigating osteoarthritis risks.
Who are the top competitors of Hy2Care?
Hy2Care's top competitors include NexGel Biotech, Bone Sci and Sumatrix Biotech.
What products or services does Hy2Care offer?
Hy2Care offers CartRevive Hydrogel Implant.
Who are Hy2Care's investors?
Hy2Care has 5 investors. Key investors include European Union, ReumaNederland, Brightlands Venture Partners, LIOF, and Startupbootcamp.